H. Pavlou

Urokinase-induced cyto-hepatolysis in a patient with acute myocardial infarction.

D. Alexopoulos, H. Pavlou, A. Panagiotopoulos, 1995, European heart journal.

Pharmacology of the class III antiarrhythmic agent sematilide in patients with arrhythmias.

D. Roden, S. Mohiuddin, S. Mohiuddin, 1992, The American journal of cardiology.

Genetically determined stereoselective excretion of encainide in humans and electrophysiologic effects of its enantiomers in canine cardiac Purkinje fibers

D. Roden, J. Turgeon, C. Prakash, 1991, Clinical pharmacology and therapeutics.

Euthyroid Sick Syndrome in Acute Ischemic Syndromes

P. Vassilakos, H. Pavlou, A. Panagiotopoulos, 2002, Angiology.

of the Class Ill Antiarrhythmic Agent Sematilide in Patients with Arrhythmias

D. Roden, S. Mohiuddin, D. Hilleman, 1992 .

Genetically-determined interaction between propafenone and low dose quinidine: role of active metabolites in modulating net drug effect.

D. Roden, H. Kroemer, C. Funck-Brentano, 1989, British journal of clinical pharmacology.

Genetically determined steady-state interaction between encainide and quinidine in patients with arrhythmias.

D. Roden, J. Turgeon, C. Funck-Brentano, 1990, The Journal of pharmacology and experimental therapeutics.